CCL21 and type 2 diabetes mellitus: Many SLC susceptibility loci have been strongly associated with metabolic diseases including insulin resistance, type 2 diabetes mellitus (T2DM), elevated blood pressure, chronic kidney disease (CKD), gout, asthma, inflammatory bowel disease (IBD), cancer, dementia, and anxiety disorders (Table 1).